HUP0104418A2 - Benzol-guanidin-származékok alkalmazása nem inzulinfüggő diabétesz mellitusz kezelésére - Google Patents
Benzol-guanidin-származékok alkalmazása nem inzulinfüggő diabétesz mellitusz kezeléséreInfo
- Publication number
- HUP0104418A2 HUP0104418A2 HU0104418A HUP0104418A HUP0104418A2 HU P0104418 A2 HUP0104418 A2 HU P0104418A2 HU 0104418 A HU0104418 A HU 0104418A HU P0104418 A HUP0104418 A HU P0104418A HU P0104418 A2 HUP0104418 A2 HU P0104418A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- formula
- het
- hal
- value
- Prior art date
Links
- AJDQRQQNNLZLPM-UHFFFAOYSA-N n-(diaminomethylidene)benzamide Chemical class NC(N)=NC(=O)C1=CC=CC=C1 AJDQRQQNNLZLPM-UHFFFAOYSA-N 0.000 title abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title abstract 2
- -1 hydroxyl- Chemical group 0.000 abstract 4
- 125000003277 amino group Chemical group 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical group O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 abstract 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/402—1-aryl substituted, e.g. piretanide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A tal lm ny t rgya (I) ltal nos képletű benzoil-guanidin-szrmazékoknak és/vagy gyógy szatilag elfogadható sóinak vagy szolvtjainak alkalmaz sa nem inzulinfüggő diabétesz mellitusz kezelésérealkalmas gyógyszerkészítmény elő llít s ra, ahol a képletben R1jelentése A csoport, R2 jelentése Het, CnFmH2n+1-mOp ltal nos képletűcsoport, R4, -OR4 ltal nos képletű csoport, hidroxil-, benzil-,cianocsoport, Hal ltal nos képletű csoport, SOq-R5, Ph, O-Ph, O-Het,NH-Het ltal nos képletű csoport, aminocsoport, NHA, NA2 vagy NH-Phltal nos képletű csoport, R3 jelentése SO2A' ltal nos képletű csoport,R4 jelentése 1-8 szénatomos egyenes vagy el gazó szénl ncúalkilcsoport vagy 3-8 szénatomos cikloalkilcsoport, amely 0, 1 , 2vagy 3 A csoportot hordozhat, R5 jelentése A vagy Ph csoport, A, A'jelentése egym stól függetlenül 1-6 szénatomos alkilcsoport, Hetjelentése mono- vagy biciklusos telített, telítetlen vagy arom sheterociklus, amely 1-4 nitrogén-, oxigén és/vagy kénatomottartalmazhat és a k"vetkezőkben felsorolt szubsztituensek k"zül 1, 2vagy 3 csoportot hordozhat: Hal ltal nos képletű csoport, trifluor-metilcsoport, A, ciano-, nitro-, amino-csoport és/vagy karbonil-oxigén-atom, Hal jelentése fluor-, klór-, bróm- vagy jódatom, Phjelentése szubsztitu latlan fenilcsoport vagy a k"vetkezőkbenfelsoroltak k"zül 1 , 2 vagy 3 csoportot hordozó fenilcsoport: A, -OAltal nos képletű csoport, Hal ltal nos képletű csoport, trifluor-metil-, aminocsoport, NHA vagy NA2 ltal nos képletű csoport, m értéke1, 2, 3, 4, 5, 6, 7 vagy legfeljebb 2n+1, n értéke 1, 2 vagy 3, p értéke 0 vagy 1, q értéke 0, 1 vagy 2. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98122419 | 1998-11-26 | ||
| PCT/EP1999/008795 WO2000030624A2 (en) | 1998-11-26 | 1999-11-16 | Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0104418A2 true HUP0104418A2 (hu) | 2002-04-29 |
Family
ID=8233036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0104418A HUP0104418A2 (hu) | 1998-11-26 | 1999-11-16 | Benzol-guanidin-származékok alkalmazása nem inzulinfüggő diabétesz mellitusz kezelésére |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1131064A2 (hu) |
| JP (1) | JP2002530325A (hu) |
| KR (1) | KR20010080597A (hu) |
| CN (1) | CN1328452A (hu) |
| AR (1) | AR023064A1 (hu) |
| AU (1) | AU1553500A (hu) |
| BR (1) | BR9915667A (hu) |
| CA (1) | CA2352154A1 (hu) |
| CZ (1) | CZ20011785A3 (hu) |
| HU (1) | HUP0104418A2 (hu) |
| ID (1) | ID29523A (hu) |
| NO (1) | NO20012563L (hu) |
| PL (1) | PL348152A1 (hu) |
| WO (1) | WO2000030624A2 (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1510207A4 (en) * | 2002-06-05 | 2008-12-31 | Inst Med Molecular Design Inc | THERAPEUTIC MEDICAMENT AGAINST DIABETES |
| US7381841B2 (en) | 2003-08-22 | 2008-06-03 | Sanofi-Aventis Deutschland Gmbh | Pentafluorosulfanylphenyl-substituted benzoylguanidines, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them |
| DE102004054847A1 (de) | 2004-11-13 | 2006-05-24 | Sanofi-Aventis Deutschland Gmbh | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4430916A1 (de) * | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Alkyl-benzoylguanidin-Derivate |
| DE4430861A1 (de) * | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Heterocyclyl-benzoylguanidine |
| DE4437874A1 (de) * | 1994-10-22 | 1996-04-25 | Merck Patent Gmbh | Alkyl-5-methylsulfonyl-benzoylguanidin-Derivate |
| DE19502644A1 (de) * | 1995-01-28 | 1996-08-01 | Merck Patent Gmbh | 4-Amino-benzoylguanidin-Derivate |
| DE19502895A1 (de) * | 1995-01-31 | 1996-08-01 | Merck Patent Gmbh | 4-Mercapto-benzoylguanidin-Derivate |
| DE19517848A1 (de) * | 1995-05-16 | 1996-11-21 | Merck Patent Gmbh | Fluorhaltige Benzoylguanidine |
| DE19531138A1 (de) * | 1995-08-24 | 1997-02-27 | Merck Patent Gmbh | Alkenyl-benzoylguanidin-Derivate |
-
1999
- 1999-11-16 JP JP2000583507A patent/JP2002530325A/ja active Pending
- 1999-11-16 ID IDW00200101318A patent/ID29523A/id unknown
- 1999-11-16 AU AU15535/00A patent/AU1553500A/en not_active Abandoned
- 1999-11-16 CA CA002352154A patent/CA2352154A1/en not_active Abandoned
- 1999-11-16 CZ CZ20011785A patent/CZ20011785A3/cs unknown
- 1999-11-16 EP EP99958047A patent/EP1131064A2/en not_active Ceased
- 1999-11-16 BR BR9915667-9A patent/BR9915667A/pt not_active Application Discontinuation
- 1999-11-16 PL PL99348152A patent/PL348152A1/xx unknown
- 1999-11-16 CN CN99813826A patent/CN1328452A/zh active Pending
- 1999-11-16 KR KR1020017006615A patent/KR20010080597A/ko not_active Application Discontinuation
- 1999-11-16 WO PCT/EP1999/008795 patent/WO2000030624A2/en not_active Application Discontinuation
- 1999-11-16 HU HU0104418A patent/HUP0104418A2/hu unknown
- 1999-11-26 AR ARP990106043A patent/AR023064A1/es unknown
-
2001
- 2001-05-25 NO NO20012563A patent/NO20012563L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR023064A1 (es) | 2002-09-04 |
| BR9915667A (pt) | 2001-08-14 |
| WO2000030624A2 (en) | 2000-06-02 |
| EP1131064A2 (en) | 2001-09-12 |
| PL348152A1 (en) | 2002-05-06 |
| KR20010080597A (ko) | 2001-08-22 |
| CA2352154A1 (en) | 2000-06-02 |
| AU1553500A (en) | 2000-06-13 |
| ID29523A (id) | 2001-09-06 |
| WO2000030624A3 (en) | 2000-10-05 |
| NO20012563D0 (no) | 2001-05-25 |
| NO20012563L (no) | 2001-05-25 |
| CZ20011785A3 (cs) | 2001-10-17 |
| JP2002530325A (ja) | 2002-09-17 |
| CN1328452A (zh) | 2001-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO306778B1 (no) | Heterocyklisk aromatisk oksazolforbindelse, mellomprodukter, farmasöytiske preparater inneholdende forbindelsene, rene cyklooksagenase-2 inhibitorer samt et antiinflammatorisk middel | |
| HUP0104964A2 (hu) | Kinazolinszármazékok, mint angiogenezis-inhibitorok, eljárás az előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
| FI970864A (fi) | Isoksatsolijohdannaiset | |
| DE122005000058I1 (de) | Depsipeptide, Herstellung und Anwendung | |
| HUP0102470A2 (hu) | Retinoidrokon receptorok funkcióját szabályozó 1,3-azol-származékok és alkalmazásuk | |
| DK0698606T3 (da) | Azolylaminderivat | |
| DK0583485T3 (da) | Ethanolaminderivater med sympathomimetiske og anti-pollakisuria-virkninger | |
| EP0671390A3 (en) | Antithrombotic agents | |
| AU5162396A (en) | Protective agent for organ or tissue | |
| HUP0104418A2 (hu) | Benzol-guanidin-származékok alkalmazása nem inzulinfüggő diabétesz mellitusz kezelésére | |
| FI920435A0 (fi) | N-(aryloxyalkyl) heteroaryl-8 -azabicyclo/3.2.1./oktaner, mellanprodukter och deras framstaellnings -foerfarande och deras anvaendning som laekemedel. | |
| AU2983792A (en) | Diaminomethyleneamino substituted substituted phenyl thiazoles | |
| NO20012443L (no) | Benzoksazolderivater og legemidler inneholdende disse som aktiv bestanddel | |
| AU676348B2 (en) | New 2(1H)-quinolone compounds, process for their preparationand the pharmaceutical compositions which contain them | |
| NO972943D0 (no) | 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse | |
| ATE56967T1 (de) | Amidderivate. | |
| NO983217L (no) | Terapeutiske anti-astmamidler som inneholder selenforbindeler | |
| FI895139A0 (fi) | Pyrrolidinderivat. | |
| EP1201664A4 (en) | BEMZIMIDAZOLE COMPOUNDS AND DRUGS CONTAINING THEM | |
| RU96115134A (ru) | Соединение 6-(2-имидазолиниламино)хинолина, пригодные в качестве агонистов альфа-2-адреноцепторов | |
| EP1500656A4 (en) | BIGUANIDE DERIVATIVE AND DIABETES TREATMENT AGENT CONTAINING | |
| DE60238847D1 (de) | Pyrimidinderivate enthaltendes medikament | |
| HUP0303026A2 (hu) | Béta-3-agonista hatású vegyületek | |
| DK0395527T3 (da) | Imidazobenzodiazepiner og deres salte, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og præparater med indhold deraf | |
| ES2122521T3 (es) | Derivados de 2'-desoxi-5-fluorouridina y sus sales farmaceuticamente aceptables, procedimiento para su preparacion y agentes antitumorales. |